Evaluating Niraparib Versus Active Symptom Control in Patients with Previously Treated Mesothelioma (NERO): a Study Protocol for a Multicentre, Randomised, Two-Arm, Open-Label Phase II Trial in UK Secondary Care Centres
BMJ OPEN（2023）
Key words
Malignant Pleural Mesothelioma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined